Compositions and methods for treating tumors presenting survivin antigens

Details for Australian Patent Application No. 2006299106 (hide)

Owner Merck Patent GmbH

Inventors Klinz, Stephan G.; Stein, Pascal Andre; Hettmann, Thore A. O.; Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2006299106

PCT Pub. Number WO2007/039192

Priority 60/721,199 27.09.05 US

Filing date 27 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 24 May 2012

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/039192 Priority application(s): WO2007/039192

24 May 2012 Application Accepted

  Published as AU-B-2006299106

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299115-Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

2006299097-Sythesis of renin inhibitors involving a cycloaddition reaction